002019.SZ

Yifan Pharmaceutical Co., Ltd. [002019.SZ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

002019.SZ Stock Summary

Top 10 Correlated Stocks

002019.SZ

In the News

002019.SZ Financial details

Company Rating
-
Market Cap
13.91B
Income
102.96M
Revenue
4.04B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4.34K
Optionable
No
Shortable
Yes
Earnings
20 Apr 2024
P/E
171.46
Forward P/E
-
PEG
-28.25
P/S
4.24
P/B
1.96
P/C
-
P/FCF
-55.52
Quick Ratio
1.08
Current Ratio
1.62
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-52.17%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-29.01%
Revenue last 5Y
-3.7%
Revenue Q/Q
-1.92%
EPS Q/Q
-13.06%
-
-
-
-
SMA20
2.33%
SMA50
22.15%
SMA100
26.58%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.01%
Gross Margin
48%
Oper. Margin
2%
Profit Margin
3%
Payout
75%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.11-16.86
52W High
-9.38%
52W Low
+61.11%
RSI
64.92
Rel Volume
5.03
Avg Volume
10.38M
Volume
52.24M
Perf Week
12.75%
Perf Month
18.66%
Perf Quarter
-
Perf Half Y
36.53%
-
-
-
-
Beta
0.954
-
-
Volatility
0.43%, 0.56%
Prev Close
5.53%
Price
14.5
Change
3.94%

Something similar

Top by Market Cap
VOO
TL0.DE
ABEA.DE
BRYN.DE
JPM
Same Sector
PSTI
SLS
GTHR
2276.HK
CURR
Top Correlated Stocks
BCE.TO
002550.SZ
2269.HK
603648.SS
1877.HK
Similar Market Cap
7030.SR
NTNX
YASKY
002025.SZ
INDIANHUME.NS

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 10.38M
  • Market Capitalization 13.91B
  • Employee 4.34K
  • CEO Mr. Xian Feng Cheng
  • Headquarters Hangzhou,CN
  • IPO Date 2004-07-13
  • Website https://www.yifanyy.com

Yifan Pharmaceutical Co., Ltd. produces and sells drugs and medicines in China and internationally. It provides drugs across gynecology, pediatrics, orthopedics, and dermatology therapeutic areas; therapeutic infusion solutions; and pantothenic acid and Provitamin B5 products. The company also provides Chinese traditional medicines, women's health products, and blood tumor drugs. In addition, it offers APIs, including feed additives/animal health products, skin and hair care ingredients, functional food additives, and fine chemicals; and PBAT/PBS biodegradable resins and PVB films. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is based in Hangzhou, China.